Nanoligent raises €12M to advance Precision Nanodrugs for Cancer Treatment
Biotech startup Nanoligent, a leader in targeted nanodrug development for cancer therapy, has secured €12 million in new funding to accelerate its clinical pipeline and manufacturing scale-up.